|
Zebrafish Models of Cancer
|
ZIABC010549
|
$572,098
|
$114,420
|
Hickstein, Dennis
|
CCR (NCI)
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-33S3
|
$600,000
|
$36,000
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-33S4
|
$75,000
|
$4,500
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
Women's Health Study: Continued Follow-up
|
5R01CA047988-21
|
$1,813,397
|
$362,679
|
BURING, JULIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Winship Cancer Institute Cancer Center Support Grant
|
2P30CA138292-04
|
$1,492,676
|
$29,854
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-04S1
|
$74,993
|
$1,500
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-04S2
|
$149,680
|
$2,994
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
WHI Hormones and Gynecologic Cancers Study
|
ZIA CP010126-10538
|
$67,541
|
$33,771
|
Wentzensen, Nicolas
|
DCEG (NCI)
|
|
Virtual Cancer Genetic Services: Telemedicine Delivery in Community Clinics
|
1R21CA164121-01A1
|
$227,184
|
$113,592
|
Bradbury, Angela
|
UNIVERSITY OF PENNSYLVANIA
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-28
|
$607,994
|
$42,560
|
Nichols, Craig
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
VCU Minority-Based Community Clinical Oncology Program
|
3U10CA052784-22S1
|
$139,963
|
$12,597
|
Hackney, Mary
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based Community Clinical Oncology Program
|
5U10CA052784-22
|
$399,112
|
$35,920
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Vascular Leukocytes Influence the Tumor Microenvironment
|
2R01CA124515-07A1
|
$318,839
|
$318,839
|
Conejo-Garcia, Jose
|
WISTAR INSTITUTE
|
|
Validation of an Antibody Test for Early Diagnosis of Ovarian Cancer
|
5R01CA160541-02
|
$315,400
|
$315,400
|
TAINSKY, MICHAEL
|
WAYNE STATE UNIVERSITY
|
|
VALIDATING AND TARGETING LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE-BETA IN CANCER
|
5R01CA131400-04
|
$336,129
|
$336,129
|
Springett, Gregory
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Vaccine-Dac/Bev Combinatorial Therapy in Ovarian Cancer
|
5R21CA156224-02
|
$348,000
|
$348,000
|
COUKOS, GEORGE
|
UNIVERSITY OF PENNSYLVANIA
|
|
Vaccine and radiation for the therapy of human cancers
|
ZIABC010975
|
$233,465
|
$23,346
|
Hodge, James
|
CCR (NCI)
|
|
Vaccine and Drug Combination Therapy for Human Cancers
|
ZIABC010661
|
$272,375
|
$27,238
|
Hodge, James
|
CCR (NCI)
|
|
Utrasensitive bioassays using palladium catalyzed chemical amplification
|
5R43CA159478-02
|
$100,578
|
$75,434
|
Lelental, Mark
|
BIOFORMATIX, INC.
|
|
Use of nanogels to target delivery of siRNA to cancer cells in mice
|
5R21CA155479-02
|
$247,687
|
$247,687
|
McDonald, John
|
GEORGIA INSTITUTE OF TECHNOLOGY
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-37S1
|
$50,000
|
$1,500
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-37S2
|
$246,000
|
$7,380
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-37S3
|
$74,999
|
$2,250
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
5P30CA014089-37
|
$6,285,726
|
$188,572
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Urine and Serum Biomarkers for Screening and Diagnosis of Ovarian Cancer
|
5R01CA108990-08
|
$551,606
|
$551,606
|
LOKSHIN, ANNA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
2U10CA035119-28
|
$820,953
|
$57,467
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
Unusual Evolutionary Patterns in BRCA1 and their Implications for Cancer
|
1F30CA171715-01
|
$32,232
|
$16,116
|
Lou, Dianne
|
UNIVERSITY OF TEXAS AUSTIN
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-26S1
|
$74,440
|
$744
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
5P30CA036727-26
|
$1,427,680
|
$14,277
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-08S1
|
$140,000
|
$18,200
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-08S2
|
$75,000
|
$9,750
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support
|
5P30CA118100-08
|
$1,934,104
|
$251,434
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
2P30CA046592-24
|
$5,694,947
|
$227,798
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-24S1
|
$49,948
|
$1,998
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-24S2
|
$74,872
|
$2,995
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Hawaii Cancer Center CCSG
|
2P30CA071789-13
|
$1,150,000
|
$69,000
|
CARBONE, MICHELE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Understanding the origin and pathogenesis of epithelial ovarian cancer
|
5F32CA159523-02
|
$55,670
|
$55,670
|
Kim, Jaeyeon
|
BAYLOR COLLEGE OF MEDICINE
|
|
Tumor Targeted Nanobins for the Treatment of Metastatic Breast and Ovarian Cancer
|
5U01CA151461-03
|
$396,261
|
$198,131
|
O'HALLORAN, THOMAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Tumor Suppressor Role of ARID1A
|
1R21CA165807-01
|
$176,175
|
$44,044
|
SHIH, IE-MING
|
JOHNS HOPKINS UNIVERSITY
|
|
Tumor -Targeting Chemotherapeutic Agents
|
5R01CA103314-21
|
$314,565
|
$78,641
|
OJIMA, IWAO
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Tulane Medical/Cancer Center Minority-Based Community Clinical Oncology Program
|
1U10CA167782-01
|
$700,000
|
$35,000
|
ROBINSON, WILLIAM
|
TULANE UNIVERSITY OF LOUISIANA
|
|
Translational Research in Cancer
|
3P30CA056036-13S1
|
$74,459
|
$1,489
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Research in Cancer
|
5P30CA056036-13
|
$2,947,311
|
$58,946
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Training of Academic Gynecologic Oncologists
|
5T32CA101642-07
|
$391,105
|
$129,065
|
BODURKA, DIANE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
TRAIL-induced Cell Death in Breast Cancer Cells
|
ZIASC007263
|
$168,252
|
$8,413
|
Lipkowitz, Stanley
|
CCR (NCI)
|
|
Tissue Array Research Program
|
ZICBC010923
|
$565,426
|
$56,543
|
Hewitt, Stephen
|
CCR (NCI)
|
|
Therapeutic Targeting Agents for Ovarian Cancer
|
3R01CA115483-08S1
|
$38,683
|
$38,683
|
LAM, KIT
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
Therapeutic Targeting Agents for Ovarian Cancer
|
3R01CA115483-08S2
|
$77,226
|
$77,226
|
LAM, KIT
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
Therapeutic Targeting Agents for Ovarian Cancer
|
5R01CA115483-08
|
$310,460
|
$310,460
|
LAM, KIT
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
The UT MD Anderson Cancer Center Community Clinical Oncology Program Research Bas
|
2U10CA045809-24
|
$1,389,595
|
$41,688
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
Total relevant funding to Ovarian Cancer for this search: $111,657,265
|